Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Jacobs

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Clinical Rheumatology|October 14, 2016
Differentiating biosimilarity and comparability in biotherapeuticsValderilio Azevedo, Brian Hassett, João Eurico Fonseca, et al.
JAMA Oncology|May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation TrialMelissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.
Oncology|April 6, 2021
The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical TrialsRobert L Coleman, J Thaddeus Beck, Joaquina C Baranda, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 19, 2024
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study designJohn D Groarke, Jeffrey Crawford, Susie M Collins, et al.
World Journal of Surgical Oncology|September 21, 2018
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of boneJacob Engellau, Leanne Seeger, Robert Grimer, et al.
The Canadian Journal of Cardiology|March 10, 2015
Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devicesLiza Grosman-Rimon, Ira Jacobs, Laura C Tumiati, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 19, 2014
Markers of inflammation in recipients of continuous-flow left ventricular assist devicesLiza Grosman-Rimon, Michael A McDonald, Ira Jacobs, et al.
Nutrients|April 13, 2023
Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic ReviewJoshua Daniel Di Vincenzo, Liam O'Brien, Ira Jacobs, et al.
The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.
Acta Oncologica (Stockholm, Sweden)|May 20, 2014
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II studyJavier Martin-Broto, Charles S Cleeland, Paul A Glare, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Rheumatology|October 14, 2016
Differentiating biosimilarity and comparability in biotherapeuticsValderilio Azevedo, Brian Hassett, João Eurico Fonseca, et al.
JAMA Oncology|May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation TrialMelissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.
Oncology|April 6, 2021
The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical TrialsRobert L Coleman, J Thaddeus Beck, Joaquina C Baranda, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 19, 2024
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study designJohn D Groarke, Jeffrey Crawford, Susie M Collins, et al.
World Journal of Surgical Oncology|September 21, 2018
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of boneJacob Engellau, Leanne Seeger, Robert Grimer, et al.
The Canadian Journal of Cardiology|March 10, 2015
Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devicesLiza Grosman-Rimon, Ira Jacobs, Laura C Tumiati, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 19, 2014
Markers of inflammation in recipients of continuous-flow left ventricular assist devicesLiza Grosman-Rimon, Michael A McDonald, Ira Jacobs, et al.
Nutrients|April 13, 2023
Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic ReviewJoshua Daniel Di Vincenzo, Liam O'Brien, Ira Jacobs, et al.
The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.
Acta Oncologica (Stockholm, Sweden)|May 20, 2014
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II studyJavier Martin-Broto, Charles S Cleeland, Paul A Glare, et al.
Pageof 9